D1 Capital Partners

Anthropic is an artificial intelligence research company dedicated to enhancing the safety and reliability of AI systems. The firm focuses on developing large-scale AI models that are interpretable, steerable, and aligned with human values. Its research encompasses various areas, including natural language processing, human feedback, scaling laws, reinforcement learning, and code generation. The company aims to produce AI systems that prioritize transparency and safety, enabling clients to better understand both the opportunities and risks associated with artificial intelligence. Anthropic's initial product, Claude, serves as an AI assistant designed for a range of tasks, reflecting the company's commitment to creating trustworthy AI solutions.

Inflammatix, Inc. is a molecular diagnostics company based in Burlingame, California, founded in 2016. The company specializes in developing rapid tests that assess the immune system to address significant clinical and public health challenges. Its primary focus is on creating diagnostics for acute bacterial and viral infections, as well as sepsis, utilizing patent-pending biomarkers exclusively licensed from Stanford University. Inflammatix employs proprietary machine-learning algorithms to analyze immune responses, producing clinically actionable results that support healthcare providers, particularly in emergency medicine, in making informed diagnostic decisions. Additionally, the company is building a diagnostics pipeline that includes tests for tropical infections, autoimmune diseases, transplant rejection, and various other conditions.

Imperative Care, Inc. is dedicated to enhancing the speed and effectiveness of acute stroke treatment through innovative medical technologies. Founded in 2015 and based in Campbell, California, the company has developed a range of solutions aimed at addressing critical needs in stroke care. Among its offerings is the Large Distal Platform, a large diameter catheter designed to reach treatment sites for both ischemic and hemorrhagic strokes. Complementing this is the ZOOM Aspiration System, a comprehensive solution that works in conjunction with the Large Distal Platform and includes various trackable reperfusion catheters for effective clot removal. By advancing stroke treatment technologies, Imperative Care aims to improve patient outcomes and optimize recovery processes for those affected by strokes.

6sense is a developer of a predictive intelligence platform that enhances revenue growth for organizations. The company utilizes artificial intelligence, big data, and machine learning to provide comprehensive visibility across the customer journey, from brand awareness to revenue generation. Its platform captures anonymous buying signals and buyer intent data, allowing sales, marketing, and customer success teams to target the right accounts effectively. By recommending optimal channels and messages, 6sense removes guesswork and inefficiencies from the sales process, leading to improved pipeline quality, accelerated sales velocity, and higher conversion rates. Through its innovative approach, 6sense aims to empower revenue teams to grow revenue predictably and efficiently.

Fireblocks Inc. is a New York-based company founded in 2018 that specializes in blockchain-based security solutions for digital asset management. Its platform is designed to securely transfer digital assets between exchanges, wallets, custodians, and counterparties, catering primarily to financial institutions such as banks, fintech companies, and hedge funds. The company employs advanced technologies, including a patent-pending chip isolation security and model predictive control (MPC), to enhance the security of assets in transit. Fireblocks enables its clients to manage and streamline their digital asset operations effectively, ensuring the protection of funds while facilitating their movement across various platforms. Additionally, Fireblocks has an operational presence in Tel Aviv, Israel.

KAVAK is an online platform that facilitates the buying and selling of used cars, primarily in Latin America. Founded in 2016 and headquartered in Mexico City, the company leverages real-time market data to provide sellers with fair offers for their vehicles, allowing transactions to be completed quickly and conveniently from home. KAVAK enhances the customer experience by offering services such as home delivery, vehicle collection, and pre-owned car financing, enabling users to navigate the car trading process with ease. The platform specializes in e-commerce within the automotive and retail sectors, making it a prominent player in the used car market.

Zetwerk is an end-to-end manufacturing supply chain solutions provider based in Bengaluru, Karnataka, India. Founded in 2018, the company operates an online marketplace that connects large manufacturing firms with vendors and suppliers for customized products, including crane parts, machine chassis, doors, and ladders. Zetwerk specializes in various manufacturing services such as die casting, sand casting, investment casting, and fabrication, allowing businesses to efficiently meet their requirements for customized components and assemblies. The platform offers collaboration and execution tools that facilitate interactions between buyers and suppliers, ensuring seamless order fulfillment. By leveraging a nationwide network of manufacturing facilities, Zetwerk enables clients to procure custom products tailored to their budget and timelines, while also supporting suppliers in expanding their order volume and revenue.

Bolt is the first European app with a mission to make cities for people, not cars. Bolt has 100 million customers in 45 countries across Europe and Africa. The company challenges personal car ownership, offering better alternatives for every use case, including ride-hailing, shared cars and scooters, and food and grocery delivery. Bolt was founded in 2013 and is headquartered in Tallinn, Estonia.

Guild's lifelong learning platform offers classes, programs, and degrees for working adults, with a path for them to move forward in their education and careers. It offers these adults support from start to finish, with their technology platform for discovery, learning, and organizing the experience, and extra support with their tech-enabled student advising model.

Inscripta, Inc. is a gene editing technology company based in Boulder, Colorado, with additional offices in Pleasanton and San Diego, California. Founded in 2015, Inscripta focuses on developing CRISPR enzymes, specifically MADzymes, for precision gene editing. The company has created a benchtop platform for scalable digital genome engineering, which includes an instrument, consumables, software, and assays that facilitate a fully automated workflow. This platform allows for massively parallel and trackable editing of single cells, significantly enhancing the scale and efficiency of gene editing research. By making its MAD7 CRISPR nuclease freely available for research and development, Inscripta aims to remove existing technical and licensing barriers, thereby empowering scientists and fostering a new era of biological discovery.

Attentive is a leading provider of conversational commerce solutions, specializing in a personalized mobile messaging platform that enhances business-to-consumer communication. The company enables brands and organizations to engage with customers using behavioral data, allowing for the automatic delivery of tailored mobile messages throughout the customer lifecycle. This includes functionalities such as product recommendations, limited-time sales, payment processing, and real-time customer service. By focusing on SMS as a primary channel, Attentive helps e-commerce and retail businesses forge stronger connections with mobile shoppers, transforming the way they interact and communicate with their audiences.

Faire is an online wholesale marketplace that connects retailers with unique merchandise from various brands and makers, facilitating a streamlined purchasing process. The platform provides retailers with tools and insights to manage inventory effectively, employing artificial intelligence and predictive analytics to forecast product demand. Faire's offerings include net 60 payment terms and free returns, which reduce the risks associated with wholesale purchasing, enabling local retailers and independent brands to compete with larger e-commerce entities. Headquartered in San Francisco and Kitchener, Faire aims to support the future of local retail by simplifying logistics and enhancing access to diverse products.

GOAT Group, established in 2015, operates a global marketplace for authentic sneakers, apparel, and accessories. It offers products from over 350 brands through its GOAT and Flight Club platforms, available in physical stores and online. GOAT Group has 13 retail locations worldwide, serving customers in 170 international markets. The company's innovative technology ensures product authenticity, providing trust to its 20 million members across 164 countries. GOAT Group is backed by strategic investors and venture capital firms, including Foot Locker, Inc.

Sight Sciences is a medical device company specializing in ophthalmic devices and glaucoma implants aimed at treating irreversible blindness. Headquartered in Menlo Park, California, the company has developed the OMNI Surgical System, which allows for targeted treatment of glaucoma by addressing three points of resistance with a single device and incision. Additionally, Sight Sciences offers TearCare, a wearable technology that delivers adjustable thermal energy to the meibomian glands to treat conditions like dry eye and meibomian gland dysfunction. The company also provides SmartLid, which aids in the natural expression of meibum when it is in a melted state. Founded in 2010, Sight Sciences focuses on both surgical and non-surgical technologies to address prevalent eye diseases and has a commercial office in Southlake, Texas.

Outset Medical, Inc. is a medical technology company based in San Jose, California, focused on innovating hemodialysis systems. The company has developed Tablo, a compact dialysis machine designed for use in both acute and chronic care settings. This system integrates essential features such as water purification, on-demand dialysate production, and advanced software capabilities, including wireless data connectivity and sensor-based automation. By simplifying the dialysis process, Tablo aims to reduce costs and enhance the experience for both patients and healthcare providers. Founded in 2003 and originally named Home Dialysis Plus, Ltd., Outset Medical rebranded in 2015 to reflect its commitment to transforming dialysis care.

GitLab Inc. is a software development company that provides a comprehensive DevSecOps platform designed to enhance the software development lifecycle. Founded in 2011 and headquartered in San Francisco, California, GitLab offers its services through a single application, which includes tools for version control, continuous integration and deployment, code reviews, issue tracking, and collaboration. This unified platform allows organizations to efficiently plan, build, secure, and deploy software while ensuring visibility and control throughout the process. GitLab serves a diverse clientele, ranging from startups to large enterprises, with an estimated 30 million registered users globally. The company operates on an all-remote model, employing over 1,350 team members across more than 65 countries. GitLab is built on open-source principles and benefits from a vibrant community of developers, continuously driving innovations in the DevOps space.

Auris Health, Inc. is a medical technology company based in Redwood City, California, that specializes in the development of robotic systems for diagnostic and therapeutic procedures. Founded in 2007, the company is known for its Monarch Platform, which enhances endoscopic procedures by utilizing flexible robotics, advanced imaging technology, and micro-instrumentation. This platform allows for minimally invasive access to the body through natural openings using small cameras and tools, thereby improving patient outcomes and potentially reducing healthcare costs. Additionally, Auris Health is working on a dual-arm microsurgical system designed for ophthalmic surgery, further expanding its focus on innovative robotic solutions for various medical applications. Auris Health operates as a subsidiary of Johnson & Johnson.